
BiosanaPharma has developed a highly flexible, comprehensive Continuous Manufacturing (CM) automation platform, suitable for all relevant GMP production scales (50L, 500L, and Our 3C platform is unit operation-independent, and with integrated automatic sampling and on/at-line analytical, a continuous downstream process (DSP) can be fully implemented within 12 to 18 months.”
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.